🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Haploidentical Hematopoietic Stem Cell Transplantation

Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy NCT04056533Phase 21 site📍 Santander Instituto de Investigación Marqués de Valdecilla · Tests: CMV CTLs Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site📍 Madison University of Wisconsin, Madison · Tests: TCRαβ+/CD19+ depleted Haploidentical HSCT, Zoledronate Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide NCT06041893n/a1 site📍 Seoul Samsung Medical Center · Tests: ATG-LDPTCy Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation NCT06008808Phase 11 site📍 St Louis Washington University School of Medicine · Tests: Ruxolitinib, Abatacept TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children NCT04414046Phase 21 site📍 St. Petersburg Johns Hopkins All Children's Hospital · Tests: Haploidentical Hematopoietic Cell Transplantation Randomised Controlled Trial Comparing CD62L and CD45RA Depleted Donor Lymphocyte Infusion With T-cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation NCT07867769Phase 21 site📍 Hong Kong Hong Kong Children's Hospital · Tests: CD62L depleted DLI, CD45RA depleted DLI, Haploidentical HSCT Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease NCT02675959Phase 24 sites📍 Los Angeles📍 Gainesville📍 Valhalla New York Medical College · Tests: Defibrotide A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant NCT07020533Phase 13 sites📍 Duarte📍 Atlanta📍 Boston City of Hope Medical Center · Tests: Biospecimen Collection, Electronic Health Record Review, Haploidentical Hematopoietic Cell Transplantation, Letermovir,… TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies NCT07052370Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Thymoglobulin, Cyclophosphamide, Fludarabine, Thiotepa, Melphalan Modified Second Haplo-transplantation for Graft Failure NCT06512545NA1 site📍 Beijing Peking University People's Hospital · Tests: second allogeneic stem cell transplantation CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation NCT06034535Phase 21 site📍 Hong Kong Hong Kong Children's Hospital · Tests: CD62L depleted donor lymphocyte infusion A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL NCT06559345Phase 21 site📍 Zhengzhou The First Affiliated Hospital of Zhengzhou University · Tests: TMLI, TBI, Cyclophosphamide CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma NCT07257419Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Anti-Thymocyte Globulin (Rabbit), Cyclophosphamide, Fludarabine, Thiotepa, Mesna Haploidentical HCT for Severe Aplastic Anemia NCT04558736Phase 21 site📍 Memphis St. Jude Children's Research Hospital · Tests: Anti-Thymocyte Globulin (Rabbit), Fludarabine, Cyclophosphamide, Mesna, G-CSF Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide NCT03533816Phase 12 sites📍 Westwood📍 Columbus University of Kansas Medical Center · Tests: EAGD T-cell infusion (Phase I), EAGD T-cell infusion (Expansion) Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study NCT06650553NA1 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT … Prophylactic DLI-X for Leukemia Relapse After HCT NCT07254793Phase 11 site📍 Tucson University of Arizona · Tests: Exercise Mobilized Prophylactic DLI, Standard Prophylactic DLI GM-CSF With Post-Transplant Cyclophosphamide NCT04237623Phase 21 site📍 Atlanta Northside Hospital, Inc. · Tests: Sargramostim, Control Arm Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression NCT05126849Phase 235 sites📍 Amiens📍 Angers📍 Besançon Assistance Publique - Hôpitaux de Paris · Tests: Allogenic transplantation Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation NCT07693881NA1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Rituximab (R) Romiplostim N01 for Platelet Recovery After Haploidentical HSCT NCT07321626Phase 11 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Romiplostim N01, Standard Supportive Care Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... NCT05470491Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: RIC, GVHD prophylaxis, allo HCT, Plerixafor, Maraviroc A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children NCT07350057Phase 11 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: 1mg /kg VIC-1911 Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations NCT01861106Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Allogeneic HSCT, Busulfan Test dose, Fludarabine (Fludara, Berlex Laboratories), Busulfan (Busulfex), Cyclophosphamide … Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy NCT03555851n/a1 site📍 Charlotte Wake Forest University Health Sciences · Tests: Cyclophosphamide, Specimen collection Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults NCT04806347Phase 11 site📍 Madison University of Wisconsin, Madison · Tests: TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome NCT05027945Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Allogeneic HSCT, Busulfan test dose, Mycophenolate mofetil (MMF), Tacrolimus, Busulfan T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338Phase 1, Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea, Rituximab, Alemtuzumab TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children NCT04356469Phase 21 site📍 St. Petersburg Johns Hopkins All Children's Hospital · Tests: Haploidentical Hematopoietic Cell Transplantation Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT. NCT06946602NA1 site📍 Beijing Peking University People's Hospital · Tests: Bu/Flu/Cy/ATG, Bu/Cy/ATG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy